Therapy of chronic myelogenous leukemia with related or unrelated donor bone marrow transplantation
McGlave, P.B.
Leukemia 6(Suppl 4): 115-117
1992
ISSN/ISBN: 0887-6924 PMID: 1434814 Document Number: 402995
Document emailed within 1 workday
Related Documents
Dini, G.; Rondelli, R.; Miano, M.; Vossen, J.; Gluckman, E.; Peters, C.; Bordigoni, P.; Locatelli, F.; Miniero, R.; Ljungman, P.; Saarinen, U.; Klingebiel, T.; Ortega, J.; Lanino, E. 1996: Unrelated-donor bone marrow transplantation for Philadelphia chromosome-positive chronic myelogenous leukemia in children: experience of eight European Countries. the EBMT Paediatric Diseases Working Party Bone Marrow Transplantation 18(Suppl 2): 80-85Drobyski, W.R.; Roth, M.S.; Thibodeau, S.N.; Gottschall, J.L. 1992: Molecular remission occurring after donor leukocyte infusions for the treatment of relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation Bone Marrow Transplantation 10(3): 301-304
Yang, Y-Li.; Lu, M-Yao.; Jou, S-Tarng.; Lin, K-Hsin.; Lin, D-Tsamn. 2005: Matched-unrelated-donor bone marrow transplantation for children with leukemia Journal of the Formosan Medical Association 104(6): 448-451
Yuen, P.; Shing, M.M.; Li, C.K.; Chik, K.W.; Hawkins, B.R. 1994: Matched unrelated donor bone marrow transplantation in Chinese children with leukemia Transplantation Proceedings 26(4): 2357
Reiffers, J.; Goldman, J.; Meloni, G.; Cahn, J.Y.; Gratwohl, A. 1994: Autologous stem cell transplantation in chronic myelogenous leukemia: a retrospective analysis of the European Group for Bone Marrow Transplantation. Chronic Leukemia Working Party of the EBMT Bone Marrow Transplantation 14(3): 407-410
del Rosario Uriarte, M.; Bonomi, R.; Azambuja, C.; Seuánez, H.N. 1997: Bone marrow reconstitution with normal autologous cells demonstrated by VNTR analysis after allogeneic bone marrow transplantation for chronic myelogenous leukemia Leukemia 11(12): 2213-2214
Santos, G.W. 1988: Problems and strategies for bone marrow transplantation in acute leukemia and chronic myelogenous leukemia Cancer Detection and Prevention 12(1-6): 589-596
Appelbaum, F.R.; Clift, R.; Radich, J.; Anasetti, C.; Buckner, C.D. 1995: Bone marrow transplantation for chronic myelogenous leukemia Seminars in Oncology 22(4): 405-411
Cunningham, I. 1990: Bone marrow transplantation for chronic myelogenous leukemia Oncology 4(11): 101-108; Discussion 108, 111
Kantarjian, H.M.; Talpaz, M. 1994: Chemotherapy and bone marrow transplantation in the treatment of chronic myelogenous leukemia Seminars in Oncology 21(6 Suppl 14: 8-13
Lin, Y.T.; Lin, D.T.; Jou, S.T.; Lin, K.S.; Lin, K.H. 1997: Allogeneic bone marrow transplantation for Philadelphia chromosome-positive chronic myelogenous leukemia in childhood Journal of the Formosan Medical Association 96(5): 320-324
Davies, S.M.; Khan, S.; Wagner, J.E.; Arthur, D.C.; Auerbach, A.D.; Ramsay, N.K.; Weisdorf, D.J. 1996: Unrelated donor bone marrow transplantation for Fanconi anemia Bone Marrow Transplantation 17(1): 43-47
Greinix, H.T.; Reiter, E.; Schulenburg, A.; Keil, F.; Lechner, K.; Fischer, G.; Rosenmayr, A.; Leitner, G.; Kalhs, P. 1998: Matched unrelated donor marrow transplantation in patients with advanced acute leukemia Bone Marrow Transplantation 22(Suppl 4): S53-S56
Gulati, S.; Acaba, L.; Yahalom, J.; Reich, L.; Motzer, R.; Crown, J.; Doherty, M.; Clarkson, B.; Berman, E.; Atzpodien, J. 1992: Autologous bone marrow transplantation for acute myelogenous leukemia using 4-hydroperoxycyclophosphamide and VP-16 purged bone marrow Bone Marrow Transplantation 10(2): 129-134
Ghavamzadeh, A.; Iravani, M.; Jabehdar-Maralani, P.; Hajrasouliha, A.; Tavakoli, S. 2003: Allogeneic peripheral blood and bone marrow stem cell transplantation for chronic myelogenous leukemia: single center study from Iran Haematologica 88(4): Elt13
Meignin, V.; Devergie, A.; Brice, P.; Brison, O.; Parquet, N.; Ribaud, P.; Cojean, I.; Gaulard, P.; Gluckman, E.; Socie, G.; Janin, A. 1998: Hodgkin's disease of donor origin after allogeneic bone marrow transplantation for myelogeneous chronic leukemia Transplantation 65(4): 595-597
Liang, J.S.; Lu, M.Y.; Tsai, M.J.; Lin, D.T.; Lin, K.H. 2000: Bone marrow transplantation from an HLA-matched unrelated donor for treatment of Chediak-Higashi syndrome Journal of the Formosan Medical Association 99(6): 499-502
Phillips, G.L.; Nevill, T.J.; Spinelli, J.J.; Nantel, S.H.; Klingemann, H.G.; Barnett, M.J.; Shepherd, J.D.; Chan, K.W.; Meharchand, J.M.; Sutherland, H.J. 1995: Prophylaxis for acute graft-versus-host disease following unrelated donor bone marrow transplantation Bone Marrow Transplantation 15(2): 213-219
Klein, J.L.; Avalos, B.R.; Belt, P.; Taylor, C.A.; Ezzone, S.A.; Scholl, M.D.; Fisher, J.; Young, D.; Copelan, E.A. 1996: Bone marrow engraftment following unrelated donor transplantation utilizing busulfan and cyclophosphamide preparatory chemotherapy Bone Marrow Transplantation 17(4): 479-483
Kaminski, E.R.; Hows, J.M.; Bridge, J.; Davey, N.J.; Brookes, P.A.; Green, J.E.; Goldman, J.M.; Batchelor, J.R. 1991: Cytotoxic T lymphocyte precursor (CTL-p) frequency analysis in unrelated donor bone marrow transplantation: two case studies Bone Marrow Transplantation 8(1): 47-50